<DOC>
	<DOC>NCT02728726</DOC>
	<brief_summary>The study is designed to determine whether patients who receive sugammadex immediately after tracheal extubation will exhibit a decrease in the incidence of postoperative residual paralysis and an associated decrease in the incidence of postoperative respiratory depression.</brief_summary>
	<brief_title>Sugammadex vs Placebo to Prevent Residual Neuromuscular Block</brief_title>
	<detailed_description />
	<mesh_term>Delayed Emergence from Anesthesia</mesh_term>
	<criteria>Patients undergoing surgery with general anesthesia Patients weighing &gt; or = 80 pounds Patients not intubated prior to surgery Patients who are able to give informed consent Patients unable to give informed consent. Patients whose condition will not allow for placement of the electrode PadSet of ExSpiron Patients who are anticipated to remain intubated in recovery period.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>100 Years</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>Postoperative respiratory depression</keyword>
	<keyword>Neuromuscular Agents</keyword>
</DOC>